1-2 of 2
Hans-Guido Wendel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR07: SETD1B mutations confer apoptosis resistance and BCL2 independence in B-cell lymphoma

Ana Portelinha, Shenqiu Wang, Sara Parsa, Man Jiang, Sagarajit Mohanty, Soumya Sharma, Neeraj Arya, Omid Tavana, Jiayu Wen, Jude Fitzgibbon, Ahmet Dogan, Ana Younes, Ari M. Melnick, Hans-Guido Wendel
Journal: Blood Cancer Discovery
Blood Cancer Discov (2024) 5 (3_Supplement): PR07.
https://doi.org/10.1158/2643-3249.LYMPHOMA24-PR07
Published: 19 June 2024
View articletitled, Abstract PR07: SETD1B mutations confer apoptosis resistance and BCL2 independence in B-cell lymphoma
Journal Articles

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Mette Staehr, Andrea V. Lopez, Khong Y. Ng, Yunxin Chen, William D. Godfrey, Terence J. Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J. Brentjens, Eric L. Smith
Journal: Blood Cancer Discovery
Blood Cancer Discov (2020) 1 (2): 146–154.
https://doi.org/10.1158/2643-3230.BCD-20-0020
Published: 01 September 2020
View articletitled, Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
Open the PDF for Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma in another window
Includes: Supplementary data